Two anti-vascular endothelial growth factor inhibitors, bevacizumab and sunitinib, have been linked to thrombotic microangiopathy, which typically subsides after stopping the drug.
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3467
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details